ARCHIVES

Degarelix Active In Phase II Trial In Prostate Cancer

This article is from The Cancer Letter archive.

Vol. 27 No. 10 | October 29, 2004

Download PDF Visit The Full Archive

Related Articles

IARC Director Denies NCI Staff Interference With Monograph

May 28, 1982

Research Opportunities Growing, $$ Shrinking, Young Tells Congress

March 29, 1991

Brandt Tells NIK There May Be No Exceptions To DRG Regulations, Maybe a Few At Comprehensive Centers

June 24, 1983

Study: Women at Higher Risk Of Estrogen Receptor Positive Breast Cancer After Smoking

February 28, 2014

Rhoads Suggests Plan For 200 Clinical Centers

January 28, 1977

FDA’s New Guideline Proposal Meets More NCI Objections

March 19, 1976